Logo for Royalty Pharma plc

Royalty Pharma Investor Relations Material

Latest events

Logo for Royalty Pharma plc

Q4 2023

Royalty Pharma
Logo for Royalty Pharma

Q4 2023

15 Feb, 2024
Logo for Royalty Pharma

Q3 2023

8 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. The company's royalty acquisition segment engages in the acquisition of royalty streams from pharmaceutical companies. Its funding segment provides equity or loan financing to biotechnology companies developing innovative methods for the treatment of cancer, inflammatory disease, obesity, diabetes, and other metabolic disorders.